Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer
Cellular Oncology Sep 25, 2017
Weixler B, et al. - Researchers, in this work, investigate the prognostic value of CXCR4 and phosphorylated CXCR4 (pCXCR4) in a large cohort of colorectal cancer (CRC) patients. As per observations, in CRC, high densities of CXCR4 and pCXCR4 positive tumor-infiltrating immune cells (TICs) are favorable prognostic factors.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
